Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H18ClN5O2S |
InChIKeyVIGHQZSTZWNWFA-UHFFFAOYSA-N |
CAS Registry959763-06-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | JP | 01 Jan 2014 |